Search Contact
Learn more about our probiotics
with exclusive mechanisms of action

Discover our
clinical research

Neuropharmagen is a precision medicine
tool especially developed for psychiatry

Patients with mental health problems treated with Neurofarmagen experience a reduction in adverse effects and respond to treatment quicker and more effectively
The Christmas holidays that have just passed were a cause for celebration for many people, but for many others it could have contributed to the worsening...
Read More
AB-Biotics organizes a round table in Moscow to discuss new probiotic treatments for Upper Respiratory Tract Infections
The  “V Federal Annual Forum Of Otolaryngologists With International Participation. Multidisciplinary Approach To Head And Neck Treatment” took place last 19th to 20th of September in...
Read More
Kaneka takes over 86.6% of AB-Biotics’ share capital
AB-Biotics has announced, as a relevant fact, that the offer to acquire shares of Kaneka, in the context of the delisting of the Spanish company, has been accepted by 2,292. 426 shares, an amount that represents 57.62% of the shares to the offerees and 18.21% of the company's share capital. In addition, through the aforementioned offer and different purchases made, Kaneka has acquired 259,762 shares in...
Read More
About ab-biotics
Research in its own
collection of more than
1.000 strains of
probiotic bacteria
Development of
advanced genetic tools
for pharmacogenetics
Precision medicine